Pemetrexed is a Intravenous Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals, Inc.. The primary component is Pemetrexed Monohydrate.
Product ID | 0480-4515_358c3982-007b-43db-8cb6-9777f9488510 |
NDC | 0480-4515 |
Product Type | Human Prescription Drug |
Proprietary Name | Pemetrexed |
Generic Name | Pemetrexed |
Dosage Form | Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-05-31 |
Marketing Category | NDA / |
Application Number | NDA208419 |
Labeler Name | Teva Pharmaceuticals, Inc. |
Substance Name | PEMETREXED MONOHYDRATE |
Active Ingredient Strength | 25 mg/mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-05-31 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0338-0720 | PEMETREXED | PEMETREXED |
0338-0722 | PEMETREXED | PEMETREXED |
0409-1045 | PEMETREXED | PEMETREXED |
0409-1060 | Pemetrexed | Pemetrexed |
0409-1061 | Pemetrexed | Pemetrexed |
0409-1062 | Pemetrexed | Pemetrexed |
0409-2188 | PEMETREXED | PEMETREXED |
0409-3532 | PEMETREXED | PEMETREXED |
0480-4514 | Pemetrexed | Pemetrexed |
0480-4515 | Pemetrexed | Pemetrexed |
0480-4516 | Pemetrexed | Pemetrexed |
0781-3518 | Pemetrexed | Pemetrexed disodium |
0781-3519 | Pemetrexed | Pemetrexed disodium |
0781-3520 | Pemetrexed | Pemetrexed disodium |
16729-229 | Pemetrexed | Pemetrexed |
16729-230 | Pemetrexed | Pemetrexed |
16729-244 | Pemetrexed | Pemetrexed |
16729-522 | Pemetrexed | Pemetrexed disodium |
50742-340 | Pemetrexed | Pemetrexed disodium |
50742-341 | Pemetrexed | Pemetrexed disodium |
55150-381 | Pemetrexed | Pemetrexed |
55150-382 | Pemetrexed | Pemetrexed |
42367-531 | Pemfexy | pemetrexed |